Efficacy of Moderna’s Next-Gen COVID-19 Vaccine Confirmed in Trial

A phase 3 trial evaluating Moderna’s next-generation COVID-19 vaccine, mRNA-1283, met its primary vaccine efficacy endpoint. The phase 3 NextCOVE study (ClinicalTrials.gov Identifier: https://classic.clinicaltrials.gov/ct2/show/NCT05815498#xd_co_f=NjM2ZGY3NjUtNmY2Zi00Yzc5LWIwOTQtYWE5ZGQwNmVlYjA3~) compared the safety, reactogenicity, relative vaccine [...]